Literature DB >> 3488857

Bacterial peptidoglycan induces in vitro rheumatoid factor production by lymphocytes of healthy subjects.

R J Levy, M Haidar, H Park, L Tar, A I Levinson.   

Abstract

The present studies were carried out to further characterize the polyclonal B cell activating properties of bacterial peptidoglycan (PG) and to determine if this ubiquitous agent induces in vitro IgM rheumatoid factor (RF) production by lymphocytes from healthy volunteers. Peripheral blood mononuclear cells (PBMC) were cultured in the presence of peptidoglycan, pokeweed mitogen (PWM), a standard polyclonal B cell activator, or additional culture medium. Supernatants were harvested on days 7-8 for determination of total IgM, total IgG, and IgM RF by an enzyme-linked immunosorbent assay (ELISA). PG and PWM induced comparable amounts of total IgM production but PG was a less potent stimulant of total IgG production. PG induced in vitro IgM-RF production in 9/33 experiments, a frequency of response of less than that observed in corresponding PWM stimulated cultures (22/33 experiments). PG-induced IgM-RF production depended upon active protein synthesis and did not correlate with the magnitude of PG-induced total IgM production. The latter finding suggests that PG-induced IgM-RF may not merely reflect polyclonal B cell activation. These results add to a growing list of PG's functional properties and provide further impetus for considering this ubiquitous agent as a potential stimulant for in vivo RF production.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3488857      PMCID: PMC1542358     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  18 in total

Review 1.  Peptidoglycan types of bacterial cell walls and their taxonomic implications.

Authors:  K H Schleifer; O Kandler
Journal:  Bacteriol Rev       Date:  1972-12

2.  Mitogenic activity of staphylococcal peptidoglycan.

Authors:  R Dziarski; A Dziarski
Journal:  Infect Immun       Date:  1979-03       Impact factor: 3.441

3.  Different populations of rheumatoid factor idiotypes induced by two polyclonal B cell activators, pokeweed mitogen and Epstein--Barr virus.

Authors:  J L Pasquali; S Fong; C D Tsoukas; S F Slovin; J H Vaughan; D A Carson
Journal:  Clin Immunol Immunopathol       Date:  1981-11

4.  In vitro synthesis of IgM rheumatoid factor by lymphocytes from healthy adults.

Authors:  W J Koopman; R E Schrohenloher
Journal:  J Immunol       Date:  1980-08       Impact factor: 5.422

5.  Opposing effects of xid and nu mutations on proliferative and polyclonal antibody and autoantibody responses to peptidoglycan, LPS, protein A and PWM.

Authors:  R Dziarski
Journal:  Immunology       Date:  1984-11       Impact factor: 7.397

6.  IgM rheumatoid factors in mice injected with bacterial lipopolysaccharides.

Authors:  S Izui; R A Eisenberg; F J Dixon
Journal:  J Immunol       Date:  1979-05       Impact factor: 5.422

7.  Polyclonal activation of immunoglobulin secretion in B lymphocytes induced by staphylococcal peptidoglycan.

Authors:  R Dziarski
Journal:  J Immunol       Date:  1980-12       Impact factor: 5.422

8.  Mitogenic responsiveness of mouse, rat and human lymphocytes to Staphylococcus aureus cell wall, teichoic acid, and peptidoglycan.

Authors:  R Dziarski; A Dziarski; A I Levinson
Journal:  Int Arch Allergy Appl Immunol       Date:  1980

9.  In vitro effects of Epstein-Barr virus on peripheral blood mononuclear cells from patients with rheumatoid arthritis and normal subjects.

Authors:  L Slaughter; D A Carson; F C Jensen; T L Holbrook; J H Vaughan
Journal:  J Exp Med       Date:  1978-11-01       Impact factor: 14.307

10.  Arthritis in rats after systemic injection of streptococcal cells or cell walls.

Authors:  W J Cromartie; J G Craddock; J H Schwab; S K Anderle; C H Yang
Journal:  J Exp Med       Date:  1977-12-01       Impact factor: 14.307

View more
  6 in total

1.  Rheumatoid factor induction in murine models of liver injury.

Authors:  U Nowak; K Gill; E Skamene; M M Newkirk
Journal:  Clin Exp Immunol       Date:  2007-02       Impact factor: 4.330

2.  Polyclonal B cell activation in ankylosing spondylitis.

Authors:  P Barbieri; I Olivieri; G Benedettini; P Marelli; M L Ciompi; G Pasero; M Campa
Journal:  Ann Rheum Dis       Date:  1990-06       Impact factor: 19.103

3.  Production of IgM rheumatoid factor by normal lymphocytes after stimulation with preparations containing IgM rheumatoid factor from patients with juvenile arthritis.

Authors:  G Nesher; T L Moore; T G Osborn; R W Dorner
Journal:  Ann Rheum Dis       Date:  1991-03       Impact factor: 19.103

4.  Histopathological and serological progression of experimental Staphylococcus aureus arthritis.

Authors:  T Bremell; A Abdelnour; A Tarkowski
Journal:  Infect Immun       Date:  1992-07       Impact factor: 3.441

5.  In vitro autoantibody production by normal adult and cord blood B cells.

Authors:  D S Pisetsky; D F Jelinek; L M McAnally; C F Reich; P E Lipsky
Journal:  J Clin Invest       Date:  1990-03       Impact factor: 14.808

6.  Correlative studies of rheumatoid factors and anti-viral antibodies in patients with rheumatoid arthritis.

Authors:  A S Ferraro; M M Newkirk
Journal:  Clin Exp Immunol       Date:  1993-06       Impact factor: 4.330

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.